Share on StockTwits

Walgreen Company (NYSE:WAG) has earned an average recommendation of “Hold” from the twenty-six analysts that are presently covering the stock, Analyst Ratings reports. Twelve research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $68.00.

Shares of Walgreen Company (NYSE:WAG) traded down 0.30% on Wednesday, hitting $70.03. The stock had a trading volume of 1,042,843 shares. Walgreen Company has a 52-week low of $43.31 and a 52-week high of $71.02. The stock has a 50-day moving average of $67.76 and a 200-day moving average of $63.03. The company has a market cap of $66.832 billion and a P/E ratio of 24.73.

Walgreen Company (NYSE:WAG) last posted its quarterly earnings results on Tuesday, March 25th. The company reported $0.91 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.93 by $0.02. The company had revenue of $19.60 billion for the quarter, compared to the consensus estimate of $19.61 billion. During the same quarter last year, the company posted $0.96 earnings per share. Walgreen Company’s revenue was up 5.1% compared to the same quarter last year. Analysts expect that Walgreen Company will post $3.44 EPS for the current fiscal year.

A number of analysts have recently weighed in on WAG shares. Analysts at Cowen and Company downgraded shares of Walgreen Company from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 14th. Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Walgreen Company in a research note on Monday, May 12th. They now have a $75.00 price target on the stock. Finally, analysts at Jefferies Group reiterated a “hold” rating on shares of Walgreen Company in a research note on Wednesday, April 30th. They now have a $69.00 price target on the stock, up previously from $62.00.

Walgreen Co (NYSE:WAG), together with its subsidiaries, operates as a retail drugstore chain in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.